Globus Medical Inc
GMED- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001237831
In the last 90 days, Globus Medical Inc insiders filed 0 open-market purchases and 4 sales; 606 institutions reported holding it in 13F filings for Q2 2026, worth $9.43B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 16, 2026
- $9.47B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $7.97M in total
- 4
- 13F holdersQ2 2026, −4 vs. previous quarter
- 606
- 13F valueReported value at the end of Q2 2026
- $9.43B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $2.94B
- +16.7% year over year
- Net income, FY2025
- $537.9M
- +422.3% year over year
- Free cash flow, FY2025
- $588.8M
- +45.3% year over year
- Revenue, Q3 FY2026
- $763.7M
- −0.7% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 9.46M
- Shares sold short
- Change
- +1.27M
- +15.5% vs. previous
- Days to cover
- 8.12
- At average daily volume
Superinvestors holding GMED, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding GMED at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Globus Medical Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2026 (view filing)6:11 PM ET | Nov 10 | 2 days | Tobin James RDirector | SSaleClass A Common Stock | −41.7K | $75.16 | −$3.13M | −100.0%0 after | 2 lots |
| Nov 5, 2026 (view filing)5:33 PM ET | Nov 4 | 1 day | Rhoads Ann DDirector | SSaleClass A Common Stock | −5.00K | $85.00 | −$425.0K | −12.4%35.4K after | 10b5-1 |
| Sep 16, 2026 (view filing)4:35 PM ET | Sep 15 | 1 day | Tobin James RDirector | SSaleClass A Common Stock | −30.0K | $74.58 | −$2.24M | −100.0%0 after | |
| Aug 19, 2026 (view filing)5:07 PM ET | Aug 18 | 1 day | Zarrilli Stephen TDirector | SSaleClass A Common Stock | −25.0K | $87.04 | −$2.18M | −100.0%0 after | |
| Jun 9, 2026 (view filing) | Jun 5 | 4 days | Davidar David DDirector | SSaleClass A Common Stock | −25.0K | $80.76 | −$2.02M | −4.7%510.2K after | |
| Feb 27, 2026 (view filing) | Feb 25 | 2 days | Huller KellyEVP, GC, Corporate Secretary | SSaleClass A Common Stock | −20.0K | $94.50 | −$1.89M | −100.0%0 after | 10b5-1 |
| Feb 17, 2026 (view filing) | Feb 12 | 5 days | Huller KellyEVP, GC, Corporate Secretary | SSaleClass A Common Stock | −10.0K | $87.67 | −$876.7K | −100.0%0 after | 10b5-1 |
| Jan 12, 2026 (view filing) | Jan 8 | 4 days | Kline KyleSenior Vice President, CFO | SSaleClass A Common Stock | −3.59K | $101.10 | −$363.4K | −100.0%0 after | 10b5-1 |
| Jan 12, 2026 (view filing) | Jan 8 | 4 days | Norwalk Leslie VDirector | SSaleClass A Common Stock | −2.00K | $101.10 | −$202.2K | −16.1%10.4K after | 10b5-1 |
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Norwalk Leslie VDirector | SSaleClass A Common Stock | −4.00K | $88.85 | −$355.4K | −24.4%12.4K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 606 holdersThe largest institutional positions in Globus Medical Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,806,724 | $853.8M | 0.01% | +309,310+2.9% | Added |
| Jupiter Topco LLC | 8,200,423 | $647.9M | 0.26% | +8,200,423 | New |
| Vanguard Capital Management LLC | 5,107,532 | $403.5M | 0.01% | +74,800+1.5% | Added |
| Vanguard Portfolio Management LLC | 4,994,385 | $394.6M | 0.02% | +114,926+2.4% | Added |
| Invesco Ltd. | 4,309,771 | $340.5M | 0.03% | −6,883−0.2% | Reduced |
| Kayne Anderson Rudnick Investment Management LLC | 4,279,730 | $338.1M | 1.05% | +4,279,730 | New |
| State Street Corp | 3,714,029 | $293.5M | 0.01% | +123,657+3.4% | Added |
| Sculptor Capital LP | 3,000,000 | $237.0M | 2.45% | −58,000−1.9% | Reduced |
| JPMorgan Chase & Co | 2,743,850 | $230.8M | 0.01% | +148,542+5.7% | Added |
| Alliancebernstein L.P. | 2,380,344 | $205.1M | 0.07% | +629,512+36.0% | Added |
Holders of 5% or more of GMED
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Globus Medical Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 8.00%10.7M shares | −1.10 ppfrom 9.10% | Feb 5, 20253 filings | Oct 27, 2026 | SEC |
| Janus Henderson Group PLC | 13G/A | 6.10%7.03M shares | +0.30 ppfrom 5.80% | Feb 11, 20217 filings | May 14, 2025 | SEC |
Politician trades
All politician trades in GMED4 members of Congress reported 15 trades in Globus Medical Inc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Oct 12, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Sep 10, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $15K-$50K |
| Apr 7, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Aug 13, 2025 | Lisa C. McClain House · MI | Sell (partial) | $1K-$15K |
| Aug 13, 2025 | Lisa C. McClain House · MI | Sell | $1K-$15K |

House · CA · Oct 12, 2026
Buy$1K-$15K

House · CA · Sep 10, 2026
Buy$15K-$50K

House · CA · Apr 7, 2026
Buy$1K-$15K

House · MI · Aug 13, 2025
Sell (partial)$1K-$15K

House · MI · Aug 13, 2025
Sell$1K-$15K